Prostate (BPH), Bladder & Urinary Tract • ICD-10-CM N30.31
Trigonitis with hematuria
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM N30.31 • 3 Linked .gov / PubMed Citations
•
Governance: Dr. Julian Sterling, MD, FACS (NPI #1376841536)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Trigonitis with hematuria Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Trigonitis with hematuria is an ICD-10-CM indexed diagnosis (N30.31) within Prostate (BPH), Bladder & Urinary Tract.
- 2 Real-world patient consensus: Federal ICD-10-CM code N30.31 categorizes Trigonitis with hematuria under Prostate (BPH), Bladder & Urinary Tract.
- 3 Typical cash cost range: Differential triage of Trigonitis with hematuria (N30.31) utilizes alpha-1 blockers [Trigonitis with hematuria N30.31].
- 4 Top reported side effects / signs: Objective lab/clinical target for Trigonitis with hematuria: IPSS Urinary Symptom in Trigonitis with hematuria (N30.31: Score) (0 – 7 (mild symptoms) (N30.31)) and Urinalysis & Post-Void in Trigonitis with hematuria (N30.31: Residual (PVR)).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Trigonitis with hematuria
What Is Trigonitis with hematuria?
Trigonitis with hematuria is an ICD-10-CM indexed diagnosis (N30.31) within Prostate (BPH), Bladder & Urinary Tract. Clinical evaluation centers on alpha-1 blockers [Trigonitis with hematuria N30.31] alongside serial IPSS Urinary Symptom in Trigonitis with hematuria (N30.31: Score) tracking (0 – 7 (mild symptoms) (N30.31)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Trigonitis with hematuria (ICD-10 N30.31) is driven by prostatic fibromuscular stromal in Trigonitis with hematuria (N30.31: hyperplasia); specialists in Prostate (BPH), Bladder & Urinary Tract monitor Urinalysis & Post-Void in Trigonitis with hematuria (N30.31: Residual (PVR)) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Trigonitis with hematuria (N30.31): weak, hesitant, or in Trigonitis with hematuria (N30.31: intermittent urinary stream)
- • Secondary Trigonitis with hematuria clinical sign: waking two or in Trigonitis with hematuria (N30.31: more times nightly)
- • Symptom flares in Trigonitis with hematuria correlating with IPSS Urinary Symptom in Trigonitis with hematuria (N30.31: Score) deviation outside 0 – 7 (mild symptoms) (N30.31)
- • Functional urology & prostate impact requiring alpha-1 blockers [Trigonitis with hematuria N30.31] evaluation (N30.31)
Trigonitis with hematuria Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N30.31 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Prostate (BPH), Bladder & Urinary Tract | NLM Clinical Tables |
| Diagnostic / Lab Marker: IPSS Urinary Symptom in Trigonitis with hematuria (N30.31: Score) | 0 – 7 (mild symptoms) (N30.31) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urinalysis & Post-Void in Trigonitis with hematuria (N30.31: Residual (PVR)) | Negative leukocyte/nitrite; PVR < 50 mL (N30.31) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Total PSA & in Trigonitis with hematuria (N30.31: Serum Creatinine/eGFR) | Age-specific PSA; eGFR > 75 mL/min (N30.31) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Trigonitis with hematuria
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Temazepam Civ Temazepam Civ Generic • RxCUI RXN-680714083-2888 | Benzodiazepine | 89% | $0.0758 | $ 11.57 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Trigonitis with hematuria)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph: What a 401-Participant Study Found With long-term follow-up, this randomized controlled trial remains negative for the primary endpoint of RFS, but was positive for CSS. European urology • 2025-12-15 • Phase III Randomized Trial | N = 401 | 87/100 | PMID 40967930 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Trigonitis with hematuria Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Trigonitis with hematuria community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Trigonitis with hematuria.